Dr. Rose has dedicated his career to immunology translational medicine and advancing new treatment options for autoimmune patients. In various leadership roles, he has brought forward more than a ...

Tests in 1,225 patients with the most deadly form of skin cancer reveal for the first time a genetic trait among most of ...

Jefferies has predicted more small tuck-in deals to come, as biotechs struggle to access capital despite key clinical ...

This decision came after the company entered into an agreement with Bristol Myers Squibb for the co-development and ...

Bristol Myers Squibb and BioNTech to co-develop cancer immunotherapy BNT327 in a deal worth up to $11.1 billion.

Australian investment manager Washington H. Soul Pattinson and building-products maker Brickworks agreed to merge into a single company. Andrew Witty, who largely led the U.S. healthcare giant from ...

BioNTech and Bristol Myers Squibb will co-develop BNT327 for solid tumors in a $1.5 billion deal with potential milestones ...

US markets opened in the red as markets digest fresh uncertainties over trade policies due to new tariffs and increasing ...

Bristol Myers Squibb has agreed to pay up to $11.1 billion to partner with Germany's BioNTech and develop the latter's ...

Almost as soon as Iranian dissident director Jafar Panahi scooped the Palme d’Or, the questions began to swirl: Would his ...

The coming months will bring a 28 Days Later sequel and a new John Wick movie starring Ana de Armas. Midsommar's Ari Aster ...

Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the Goldman Sachs 46 th Annual Global Healthcare Conference on Wednesday, June 11, 2025.